Treatment of Acute Bacterial Sinusitis
For most adults with acute bacterial sinusitis, start with amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days, as this provides optimal coverage against resistant organisms including β-lactamase-producing bacteria. 1
Initial Diagnostic Considerations
Before initiating antibiotics, distinguish between viral and bacterial sinusitis:
- Viral rhinosinusitis (the common cold) is the most common cause and does not require antibiotics 2
- Bacterial sinusitis should be suspected when symptoms persist beyond 10 days without improvement, or when severe symptoms (high fever ≥39°C with purulent nasal discharge) occur for 3-4 consecutive days, or when symptoms worsen after initial improvement 3
- Watchful waiting for 7 days without antibiotics is appropriate for uncomplicated cases in adults when follow-up can be assured, starting antibiotics only if no improvement occurs 1
First-Line Antibiotic Selection
Standard Adult Dosing
Amoxicillin-clavulanate is preferred over plain amoxicillin because β-lactamase-producing H. influenzae and M. catarrhalis have become increasingly prevalent, and the clavulanate component provides essential coverage against these organisms 1, 3
- Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days 1
- Plain amoxicillin 500-875 mg twice daily remains acceptable only for uncomplicated cases without recent antibiotic exposure 1
- Treatment duration: 5-10 days, with most guidelines recommending continuation until symptom-free for 7 days 1
- Shorter 5-7 day courses have comparable efficacy with fewer side effects 1
Pediatric Dosing
- High-dose amoxicillin 80-90 mg/kg/day in 2 divided doses for areas with high prevalence of resistant S. pneumoniae 1
- Amoxicillin-clavulanate 80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses for children with risk factors (age <2 years, daycare attendance, recent antibiotic use) 1
Penicillin-Allergic Patients
Second- and third-generation cephalosporins are the preferred alternatives, as the risk of cross-reactivity in penicillin-allergic patients is negligible 1
Recommended Cephalosporins
- Cefuroxime-axetil (second-generation) 1
- Cefpodoxime-proxetil (third-generation, superior activity against H. influenzae) 1
- Cefdinir (third-generation, excellent coverage) 1
- For pediatric penicillin allergy: cefpodoxime proxetil 8 mg/kg/day in two doses 1
Critical Pitfall to Avoid
Never use azithromycin or other macrolides as first-line therapy due to 20-25% resistance rates among S. pneumoniae and H. influenzae 1
Treatment Failure Protocol
Reassess at 72 hours (pediatrics) or 3-5 days (adults) if no improvement occurs 1
Second-Line Options
When first-line therapy fails or for complicated sinusitis:
- Respiratory fluoroquinolones: Levofloxacin 500-750 mg once daily or moxifloxacin 1, 4
- Fluoroquinolones provide 90-92% predicted clinical efficacy and 100% microbiologic eradication of S. pneumoniae, including multi-drug resistant strains 1
- Reserve fluoroquinolones specifically for treatment failures, complicated sinusitis (frontal, ethmoidal, or sphenoidal involvement), or multi-drug resistant organisms to prevent resistance development 1
Anatomic Location-Based Treatment
Maxillary Sinusitis (Most Common)
- Standard first-line antibiotics (amoxicillin-clavulanate) 1
- Symptoms: unilateral/bilateral infraorbital pain worsening when bending forward, pulsatile, peaking evening/night 1
Frontal, Ethmoidal, or Sphenoidal Sinusitis
- Consider fluoroquinolones (levofloxacin or moxifloxacin) due to potential for serious complications 1
Adjunctive Therapies
Intranasal Corticosteroids
- Recommended as adjunct to antibiotic therapy in both acute and chronic sinusitis 2, 1
- Continue for 3 months when cough disappears with therapy 2
Oral Corticosteroids
- Short-term use (e.g., dexamethasone 4 mg) may be beneficial for acute hyperalgic sinusitis (severe pain) or marked mucosal edema 1
- Should never be used as monotherapy; always combine with appropriate antibiotics 1
Decongestants
- Oxymetazoline hydrochloride for 5 days maximum 2
- No prospective randomized trials prove efficacy of nasal or oral decongestants, but clinical experience supports their use 2
Supportive Measures
- Adequate hydration, analgesics, warm facial packs, sleeping with head elevated 1
Critical Pitfalls to Avoid
- Inadequate treatment duration leads to relapse - ensure minimum 5 days, typically 7-10 days total 1
- Overuse of fluoroquinolones promotes resistance - reserve for treatment failures or complicated cases 1
- Failure to reassess at appropriate intervals - check at 72 hours (pediatrics) or 3-5 days (adults) 1
- Using macrolides as first-line therapy - resistance rates are too high 1
- Stopping antibiotics when symptoms improve - complete the full course to prevent relapse 1